James E. Krook

557 total citations
9 papers, 427 citations indexed

About

James E. Krook is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, James E. Krook has authored 9 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in James E. Krook's work include Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). James E. Krook is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). James E. Krook collaborates with scholars based in United States and Canada. James E. Krook's co-authors include John Foley, Carl G. Kardinal, Loren K. Tschetter, B. Norris, Stephen A. Cullinan, Charles G. Moertel, John F. Barlow, Harry S. Wieand, Allan J. Schutt and John W. Kugler and has published in prestigious journals such as Cancer, Journal of neurosurgery and Investigational New Drugs.

In The Last Decade

James E. Krook

9 papers receiving 414 citations

Peers

James E. Krook
Natalyn Hawk United States
Pamela Biondani Italy
Lisa Hazard United States
Noël Stremsdoerfer France
Maria Antonietta Satolli Italy
H. Franklin Netherlands
A Iveson United Kingdom
Sonia Yip Australia
E. Bonetto Italy
Iveta Kudaba Latvia
Natalyn Hawk United States
James E. Krook
Citations per year, relative to James E. Krook James E. Krook (= 1×) peers Natalyn Hawk

Countries citing papers authored by James E. Krook

Since Specialization
Citations

This map shows the geographic impact of James E. Krook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Krook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Krook more than expected).

Fields of papers citing papers by James E. Krook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Krook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Krook. The network helps show where James E. Krook may publish in the future.

Co-authorship network of co-authors of James E. Krook

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Krook. A scholar is included among the top collaborators of James E. Krook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Krook. James E. Krook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Edmonson, John H., John Q. Su, & James E. Krook. (2010). Treatment of ovarian cancer in elderly women: Mayo clinic-north central cancer treatment group studies. Cancer. 71(S2). 615–617. 10 indexed citations
2.
Edmonson, John H., Vera J. Suman, Robert J. Dalton, et al.. (2001). Comparison of Conventional Dose and Double Dose Carboplatin in Patients Receiving Cyclophosphamide Plus Carboplatin for Advanced Ovarian Carcinoma: A North Central Cancer Treatment Group Study. Cancer Investigation. 19(6). 597–602. 7 indexed citations
3.
Kardinal, Carl G., et al.. (1996). Octreotide as first-line treatment for women with metastatic breast cancer. Investigational New Drugs. 14(2). 235–237. 18 indexed citations
4.
Buckner, Jan C., Loren D. Brown, John W. Kugler, et al.. (1995). Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma. Journal of neurosurgery. 82(3). 430–435. 49 indexed citations
5.
Ingle, James N., et al.. (1995). Evaluation of Ifosfamide Plus Mesna as First-Line Chemotherapy in Women with Metastatic Breast Cancer. American Journal of Clinical Oncology. 18(6). 498–501. 5 indexed citations
6.
Hartmann, Lynn C., Lester E. Wold, Gist H. Farr, et al.. (1994). Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol. Cancer. 74(11). 2956–2963. 85 indexed citations
7.
8.
Krook, James E., H. Samuel Wieand, Robert W. Beart, et al.. (1991). A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer. 67(10). 2454–2458. 81 indexed citations
9.
Cullinan, Stephen A., Charles G. Moertel, Harry S. Wieand, et al.. (1990). A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin. Cancer. 65(10). 2207–2212. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalyn Hawk Breakdown of academic impact, for papers by Pamela Biondani Breakdown of academic impact, for papers by Lisa Hazard Breakdown of academic impact, for papers by Noël Stremsdoerfer Breakdown of academic impact, for papers by Maria Antonietta Satolli Breakdown of academic impact, for papers by H. Franklin Breakdown of academic impact, for papers by A Iveson Breakdown of academic impact, for papers by Sonia Yip Breakdown of academic impact, for papers by E. Bonetto Breakdown of academic impact, for papers by Iveta Kudaba
Rankless by CCL
2026